Zenotech Laboratories (BOM:532039) Total Liabilities: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532039 Zenotech Laboratories Ltd BOM:532039
74 GF Score
Price ₹45.00
GF Value ₹64.66
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Zenotech Laboratories Total Liabilities?

Zenotech Laboratories BOM:532039 +1.24% 74 Total Liabilities is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:532039 with a GF Score™ of 74/100 and a GF Value™ of ₹64.66 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Zenotech Laboratories's Total Liabilities for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Zenotech Laboratories's quarterly Total Liabilities increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹160.32 Mil) but then declined from Mar. 2026 (₹160.32 Mil) to Jun. 2026 (₹0.00 Mil).

Zenotech Laboratories's annual Total Liabilities declined from Mar. 2024 (₹156.65 Mil) to Mar. 2025 (₹149.00 Mil) but then increased from Mar. 2025 (₹149.00 Mil) to Mar. 2026 (₹160.32 Mil).

Zenotech Laboratories Total Liabilities Historical Data

* Premium members only.

The historical data trend for Zenotech Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenotech Laboratories Total Liabilities Chart

Zenotech Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 234.44 186.03 156.65 149.00 160.32

Zenotech Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 146.52 0.00 160.32 0.00
BOM:532039
74GF Score
Zenotech Laboratories Ltd BOM:532039
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenotech Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zenotech Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=120.564+(0+39.76
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=160.3

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=1111.535-951.211
=160.3

Zenotech Laboratories's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=N/A

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹0.0 Mil mean?
Zenotech Laboratories (BOM:532039) has a Total Liabilities of ₹0.0 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Zenotech Laboratories and its competitors.
Is Zenotech Laboratories' Total Liabilities too high?
Zenotech Laboratories' current Total Liabilities is ₹0.0 Mil. Overall, Zenotech Laboratories has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenotech Laboratories' Total Liabilities compare to ZTS?
Zenotech Laboratories' Total Liabilities of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Zenotech Laboratories and its competitors. Zenotech Laboratories's current Total Liabilities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenotech Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Zenotech Laboratories (BOM:532039) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹64.66, compared to a current price of ₹45.00 — trading 30.4% below its estimated fair value. The current Total Liabilities is ₹0.0 Mil. Zenotech Laboratories' overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Zenotech Laboratories (BOM:532039), the current Total Liabilities is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenotech Laboratories (BOM:532039) Overvalued in 2026?

Based on GuruFocus' analysis, Zenotech Laboratories stock appears to be undervalued. The current stock price of ₹45.00 is trading 30.4% below its estimated GF Value™ of ₹64.66. GuruFocus considers Zenotech Laboratories to be Significantly Undervalued.

Key valuation signals for BOM:532039:

  • Total Liabilities: ₹0.0 Mil
  • GF Value™: ₹64.66 vs. price of ₹45.00 (30.4% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the BOM:532039 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zenotech Laboratories Business Description

Address Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.
74GF Score

Get the complete analysis for BOM:532039

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹45.00
Price
₹64.66
GF Value